Results 151 to 160 of about 167,339 (316)
Difficulties in differentiating the nature of ascites based on ultrasound imaging
, 2017 Transabdominal ultrasound not always allows to determine the nature of ascites based solely on its characteristics. Aim: The aim of the study was to present difficulties in determining the nature of ascites using transabdominal ultrasonography solely ...
Elżbieta Bernatowicz +2 more
core +1 more source
Emerging treatment options for management of malignant ascites in patients with ovarian cancer
, 2012 Ramez N Eskander, Krishnansu S TewariDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California at Irvine, Irvine, CA, USAAbstract: Malignant ascites affects approximately 10% of patients with recurrent epithelial
Eskander RN, Tewari KS
core
[Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis]
, 2009 Ascites and hyponatremia are frequent complications of advanced liver cirrhosis. Over 50 % of cirrhotic patients develop ascites and about one third gets hyponatremic.
Ackermann, Daniel
core
Current Progress in Differentiating Crohn's Disease From Intestinal Tuberculosis
iLABMED, EarlyView.Currently, there are various methods from different fields used to differentiate Crohn's disease from intestinal tuberculosis (ITB). Endoscopic findings are an important cornerstone. They can be used individually or in combination (models) to demonstrate excellent discriminative ability.
Chuyao Zhang, Xiaoyin Zhang
wiley +1 more source
Pathophysiology of ascites formation in cirrhosis of the liver [PDF]
, 1991 Gerbes, Alexander L.
core +1 more source
iNew Medicine, EarlyView.ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid +4 more
wiley +1 more source
Potent monoclonal antibodies against multidrug‐resistant hypervirulent Klebsiella pneumoniae
Interdisciplinary Medicine, EarlyView.A novel immunization strategy using a low‐virulence, multidrug‐resistant strain yields synergistic monoclonal antibodies against hypervirulent Klebsiella pneumoniae. These antibodies provide cross‐serotype protection through a dual‐mechanism of pathogen clearance and immunomodulation, offering a promising non‐antibiotic therapeutic for resistant ...
Yushan Jiang +10 more
wiley +1 more source
Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication
Journal of Clinical Laboratory Analysis, EarlyView.Up‐to‐date, tumor markers are considered more helpful in the evaluation of treatment response and prognostication rather than diagnosis. Identifying a valid biomarker to help clinical management of hepatocellular carcinoma (HCC) is still a challenge, especially the alpha‐fetoprotein (AFP) negative HCC. This study evaluated the efficacy of serum Midkine
Yanfang Luo +3 more
wiley +1 more source